← Leaderboards
Christopher Yanucil
University Of Alabama At Birmingham
$2,060,879
Attributed
$2,060,879
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $606.5K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,060,879 · 2
By mechanism
R44$1,954,883 · 1
F31$105,996 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Phillip Darwin Bell$6,180,253
- Isaac D Campos$143,420
- Kylie Heitman$143,421
- Alayne Denise Markland$7,052,592
- Kenneth G Saag$51,918,369
Others in their field
Other Emerging Leaders on “Heart”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Ashlin Bolton · Broad Institute, Inc.$22,970,454
- Lisa Newman · Research Triangle Institute$22,725,934
- Craig Reist · Research Triangle Institute$22,725,934
Research focus
HeartKidneyDialysis ProcedureGeneticInorganic PhosphateIntegral Membrane ProteinCause Of DeathCellsFibroblast Growth Factor 23Fibroblast Growth Factor ReceptorsHormonesHypertrophyCessation Of LifeChronic Kidney FailureBoneBindingCardiacAnimal ModelCardiac MyocytesExcretory FunctionCardiovascular DiseasesCardiovascular SystemHeart HypertrophyMediating
Grant awards (7)
Design of a bioactive mimetic of soluble klotho for the treatment of chronic kidney disease$548,801
R44 · FY2025 · DK · contact PI
Design of a bioactive mimetic of soluble klotho for the treatment of chronic kidney disease$543,558
R44 · FY2024 · DK · contact PI
Design of a bioactive mimetic of soluble klotho for the treatment of chronic kidney disease$606,474
R44 · FY2023 · DK · contact PI
Design of a bioactive mimetic of soluble klotho for the treatment of chronic kidney disease$256,050
R44 · FY2022 · DK · contact PI
Vitamin D and soluble Klotho inhibit FGF23-mediated cardiac hypertrophy in Chronic Kidney Disease$35,820
F31 · FY2019 · DK · contact PI
Vitamin D and soluble Klotho inhibit FGF23-mediated cardiac hypertrophy in Chronic Kidney Disease$35,328
F31 · FY2018 · DK · contact PI
Vitamin D and soluble Klotho inhibit FGF23-mediated cardiac hypertrophy in Chronic Kidney Disease$34,848
F31 · FY2017 · DK · contact PI